Filter

Showing 581–600 of 717 results

Placeholder

Full Length Transmembrane Proteins

Human 5HT2A full length protein-synthetic nanodisc

SKU:  FLP100166     Target:  5HT2A

Price: 10 μg $900.00 ; 50 μg $4400.00 ; 100 μg $8000.00

Placeholder

Full Length Transmembrane Proteins

Human 5HT1E full length protein-synthetic nanodisc

SKU:  FLP100164     Target:  5HT1E

Price: 10 μg $900.00 ; 50 μg $4400.00 ; 100 μg $8000.00

Placeholder

Full Length Transmembrane Proteins

Human 5HT1F full length protein-synthetic nanodisc

SKU:  FLP100165     Target:  5HT1F

Price: 10 μg $900.00 ; 50 μg $4400.00 ; 100 μg $8000.00

Placeholder

Full Length Transmembrane Proteins

Human 5HT1D full length protein-synthetic nanodisc

SKU:  FLP100163     Target:  5HT1D

Price: 10 μg $900.00 ; 50 μg $4400.00 ; 100 μg $8000.00

Placeholder

Full Length Transmembrane Proteins

Human 5HT1B full length protein-synthetic nanodisc

SKU:  FLP100162     Target:  5HT1B

Price: 10 μg $900.00 ; 50 μg $4400.00 ; 100 μg $8000.00

Placeholder

Full Length Transmembrane Proteins

Human 5HT1A full length protein-synthetic nanodisc

SKU:  FLP100161     Target:  5HT1A

Price: 10 μg $900.00 ; 50 μg $4400.00 ; 100 μg $8000.00

page-FLP100153 OR8U8 Fig.2 SDS PAGE 1

Full Length Transmembrane Proteins

Human OR8U8 full length protein-synthetic nanodisc

SKU:  FLP100153     Target:  OR8U8

Price: 10 μg $900.00 ; 50 μg $4400.00 ; 100 μg $8000.00

page-FLP100154 TAS1R3 Fig.2 SDS PAGE 1

Full Length Transmembrane Proteins

Human TAS1R3 full length protein-synthetic nanodisc

SKU:  FLP100154     Target:  TAS1R3

Price: 10 μg $900.00 ; 50 μg $4400.00 ; 100 μg $8000.00

page-FLP100152 OR1E1 Fig.2 SDS PAGE 1

Full Length Transmembrane Proteins

Human OR1E1 full length protein-synthetic nanodisc

SKU:  FLP100152     Target:  OR1E1

Price: 10 μg $900.00 ; 50 μg $4400.00 ; 100 μg $8000.00

page-FLP100151 OR2B3 Fig.2 SDS PAGE 1

Full Length Transmembrane Proteins

Human OR2B3 full length protein-synthetic nanodisc

SKU:  FLP100151     Target:  OR2B3

Price: 10 μg $900.00 ; 50 μg $4400.00 ; 100 μg $8000.00

Placeholder

Full Length Transmembrane Proteins

Human OR3A1 full length protein-synthetic nanodisc

SKU:  FLP100150     Target:  OR3A1

Price: 10 μg $900.00 ; 50 μg $4400.00 ; 100 μg $8000.00

page-FLP100149 EMP2 Fig.2 SDS PAGE 1

Full Length Transmembrane Proteins

Human EMP2 full length protein-synthetic nanodisc

SKU:  FLP100149     Target:  EMP2

Price: 10 μg $900.00 ; 50 μg $4400.00 ; 100 μg $8000.00

elisa-FLP100148 ILDR2 Fig.1 Elisa 1

Full Length Transmembrane Proteins

Human ILDR2 full length protein-synthetic nanodisc

SKU:  FLP100148     Target:  ILDR2

Price: 10 μg $900.00 ; 50 μg $4400.00 ; 100 μg $8000.00

elisa-FLP100145 CGRPR RAMP1 Fig.1 Elisa 1

Full Length Transmembrane Proteins

Human CGRPR-RAMP1 full length protein-synthetic nanodisc

SKU:  FLP100145     Target:  CGRPR

Price: 10 μg $900.00 ; 50 μg $4400.00 ; 100 μg $8000.00

elisa-FLP100147 PLA2R1 Fig.1 Elisa 1

Full Length Transmembrane Proteins

Human PLA2R1 full length protein-synthetic nanodisc

SKU:  FLP100147     Target:  PLA2R1

Price: 10 μg $900.00 ; 50 μg $4400.00 ; 100 μg $8000.00

elisa-FLP100146 TLR9 Fig.1 Elisa 1

Full Length Transmembrane Proteins

Human TLR9 full length protein-synthetic nanodisc

SKU:  FLP100146     Target:  TLR9

Price: 10 μg $900.00 ; 50 μg $4400.00 ; 100 μg $8000.00

page-FLP100144 TLR7 Fig.2 SDS PAGE 1

Full Length Transmembrane Proteins

Human TLR7 full length protein-synthetic nanodisc

SKU:  FLP100144     Target:  TLR7

Price: 10 μg $900.00 ; 50 μg $4400.00 ; 100 μg $8000.00

page-FLP100143 TLR5 Fig.2 SDS PAGE 1

Full Length Transmembrane Proteins

Human TLR5 full length protein-synthetic nanodisc

SKU:  FLP100143     Target:  TLR5

Price: 10 μg $900.00 ; 50 μg $4400.00 ; 100 μg $8000.00

page-FLP100142 CAV1 Fig.2 SDS PAGE 1

Full Length Transmembrane Proteins

Human CAV1 full length protein-synthetic nanodisc

SKU:  FLP100142     Target:  CAV1

Price: 10 μg $900.00 ; 50 μg $4400.00 ; 100 μg $8000.00

page-FLP100141 TLR4 Fig.2 SDS PAGE 1

Full Length Transmembrane Proteins

Human TLR4 full length protein-synthetic nanodisc

SKU:  FLP100141     Target:  TLR4

Price: 10 μg $900.00 ; 50 μg $4400.00 ; 100 μg $8000.00

Posts found

The structure of MSP-Nanodisc (left) and Synthetic Nanodisc (right)
Synthetic Nanodisc, A Promising Solution for “Undruggable” Membrane Proteins

[...]

26
Jul
The glucagon receptor (GCGR)：A Key Target in Glucose Metabolism

On June 25, 2024, at the 2024 American Diabetes Association (ADA) Scientific Sessions, Suzhou Innovent Biologics [...]

29
Aug
the structure of GPL1R
GLP1R Target: Not Just for Blood Sugar Control and Weight Loss, but a Potential Breakthrough for Anti-Nausea in Weight Loss Medications

Currently, the most popular GLP1-based monotherapy, Semaglutide, controls blood sugar by promoting insulin secretion and [...]

19
Aug
The structure of GIPR
GIP Receptor (GIPR): A Novel Target for Glycemic Control and Weight Loss

On February 27, 2024, Viking Therapeutics announced the results of their Phase IIa clinical study [...]

08
Aug
Discover DIMA at Membrane Protein Paris 2024
2024-07-26

Membrane proteins are essential for cell functions such as maintaining cellular physiological processes, playing crucial [...]

The structure of STEAP1
STEAP1 – A Therapeutic Target for Prostate Cancer

At the 2024 ASCO Annual Meeting, HANGZHOU DAC BIOTECHNOLOGY (abbreviated as DAC Biotech) presented preclinical [...]

03
Jul
The structure of Claudin proteins enables the Claudins tight protein family to effectively maintain the polarity of epithelial and endothelial cells.
Tumor Immune Target – Claudin18.2

Since Ganymed unveiled the efficacy data of Zolbetuximab (IMAB362), the anti-Claudin18.2 monoclonal antibody, for the [...]

18
Apr
ActRII signaling pathway
ActRII – A Novel Drug Target that Preserves Skeletal Muscle Mass and Enhances Fat Loss

In the previous article, we focused on the popular drug target for weight loss, G [...]

10
Apr
20-HETE Receptor (GPR75) Signaling in Endothelial Cells
GPR75 – An Emerging Target for Weight Loss Drugs

When it comes to weight loss medications, one cannot overlook the remarkable success of Semaglutide [...]

01
Apr
Proposed role of HSD17B13 in modulating disease progression in NAFLD
HSD17B13-NASH Therapeutic Emerging Target

On November 30, 2023, Inipharm, a pharmaceutical company focused on severe liver diseases, announced the [...]

19
Feb

Pages found

Mammalian Cell Protein Production Platform

revolutionizing-drug-development-synthetic-nanodiscs

Synthetic Nanodisc

Case Study on Membrane Protein

Product case studies

DiMProTM Full Length Transmembrane Proteins

FAQ

Company Introduction

Company News